This is Part 3 of a four-part series on how Vega Health approaches healthcare AI differently than others. Part 1 explored why infrastructure matters. Part 2 examined how to access validated AI solutions. This piece addresses the critical challenge of how to measuring whether the solutions you've selected are actually delivering the value you expect.
You've built the infrastructure. You've selected an AI solution from a validated source to address a specific use case. Now you have to prove it's actually delivering results and advancing a strategic priority for your health system.
Maybe the vendor showed you impressive metrics from their development environment. Perhaps they even promised specific improvements: reduced readmissions, faster diagnosis, or more streamlined workflows. But here's the question that keeps health system leaders up at night: Can we truly demonstrate this solution is helping us meet our goals – in our environment, for our clinicians, with our patients?
Very rarely can health systems answer this question. It's not because they don't want to, but because of two key factors: there's no mandate for vendors to report post-implementation monitoring performance; and very few healthcare delivery organizations have the resources, infrastructure, and expertise to comprehensively monitor AI solutions. This lack of transparency creates a market where health systems can be locked into a solution without visibility into its impact, and vendors minimize accountability for long-term performance.
The Limitations of Today's Monitoring Approach
Research consistently shows that 80% of healthcare AI projects fail to scale beyond pilot phases, with some studies indicating failure rates as high as 95% when measured by return on investment. These aren't necessarily technology failures. But they are failures of the industry to properly equip health system leaders with the metrics they need to make informed decisions.
Despite frameworks proposed by organizations like the Health AI Partnership, there is no standardized approach mandated in the commercial market. Most healthcare organizations lack the technical infrastructure for comprehensive monitoring: only 2% of AI implementation studies document economic outcomes, and fewer than half report patient benefits or track adverse events.
AI solution vendors who do have monitoring capabilities are not incentivized to transparently share performance data. Those vendors' incentives are to keep selling, not reveal complete performance data if it could jeopardize the customer relationship. Even existing monitoring typically focuses on a single dimension: technical performance. You may see accuracy metrics or usage statistics, but not whether clinicians are using the tool appropriately, whether it's improving outcomes, or whether it's delivering the value you were promised.
What Comprehensive Monitoring Actually Requires
Effective monitoring requires assessing AI performance across four interconnected dimensions. Missing any one will give you an incomplete picture.
Technical Accuracy and Model Fidelity
Technical performance is the foundation, but real-world assessment differs substantially from in-silico validation conducted on retrospective datasets. Models built in a specific clinical environment often perform differently in other settings due to differences in patient populations or care delivery processes. In dynamic clinical environments, AI model performance can drift: changes in patient populations, evolving clinical practices, or shifts in data quality can all degrade performance over time.
Vega Health monitors continuously, tracking not just aggregate accuracy but performance across patient subpopulations to detect model biases that could result in disparate impacts. Our platform architecture tracks data quality of model inputs, because even technically sound models produce unreliable results when fed incomplete, non-conformant, or implausible data. We also watch for “feedback loops”—scenarios where successful AI-driven interventions change outcome distributions in ways that can make model performance appear to degrade when it’s actually working as intended.
User Adoption and Clinical Integration
Technical accuracy means nothing if clinicians don't use AI solutions appropriately, or if the tools create frictions in clinical workflows. The second dimension tracks how AI solutions integrate into actual practice.
We measure override rates, time-to-action on AI-generated alerts, and patterns of engagement that reveal whether tools provide trusted insights or generate alert fatigue. A model with excellent technical metrics might generate alerts when clinicians can't act on them or in formats that require excessive cognitive burden to interpret. High override rates could indicate poor positive predictive value, or they might reveal workflow misalignment and insufficient training. This monitoring must be ongoing because adoption patterns shift as staff turn over, workflows evolve, clinical guidelines change, or simply because staff become more accustomed to using a new tool.
Clinical and Operational Outcomes
The third dimension assesses whether AI systems achieve their intended objectives. Technical accuracy and user adoption are necessary, but insufficient. The central question remains: Does the AI solution you've purchased really deliver progress against the key use case outcomes you originally identified?
This requires connecting AI implementation to downstream results. Does the sepsis prediction and alerting system reduce mortality or time-to-treatment? Does the chronic disease management tool reduce hospitalizations? Does the prior authorization solution save staff time and reduce write-offs?
Success metrics vary widely and should be defined at the use-case level before implementation. Baseline measurements must be established, and data collection must continue through post-implementation. Time horizons for outcome measures vary by use case: chronic disease management tools may require months or years to measure outcomes; acute care may require days or weeks. This dimension reveals whether specific patient populations benefit, whether outcomes improve consistently across contexts, and whether benefits are sustained over time.
Return on Investment and Value Capture
The fourth dimension evaluates value capture, which will be financial for many use cases. Vega Health tracks both tangible returns and harder-to-quantify improvements like clinician satisfaction, faster decision-making, and reduced cognitive burden.
ROI monitoring must account for the full implementation lifecycle. Initial investments may exceed short-term benefits, making it critical to track value capture over appropriate time horizons. AI solutions often deliver value differently than anticipated: a tool designed to improve diagnostic accuracy may deliver value through workflow efficiency gains.
Without systematic measurement across all four dimensions, healthcare organizations cannot distinguish successful investments from expensive failures.
The Objectivity Problem
Health systems want objective evidence about whether AI solutions are working. What they are offered from vendors may or may not reflect reality. This isn't malicious. It's structural. Vendors have business incentives to highlight positive results and downplay problems. They may track only technical metrics while ignoring adoption challenges, report aggregate performance while ignoring harder-to-reach subpopulations, or show short-term wins without tracking sustained benefits.
Most problematically, vendors themselves may lack the infrastructure or visibility to capture the full picture. They may not be able to access your EHR data to measure clinical outcomes, observe clinical workflows to assess integration challenges, or connect AI performance to your operational metrics or financial returns.
Even your EHR vendor has minimal incentive to robustly monitor and report their own AI capabilities. Their incentive is to promote adoption of their tools over potentially superior alternatives and they benefit from keeping you within their ecosystem rather than objectively evaluating whether external solutions might serve you better.
What health systems need is a partner whose success depends on finding what actually works.
How Vega Health Enables Comprehensive Monitoring
This is where our platform infrastructure (Part 1) and curated marketplace (Part 2) come together to solve the monitoring challenge.
The Vega Health Platform operates within your local environment, behind your firewall, giving the system the access needed to monitor across all four dimensions while you maintain complete data governance. We integrate with your EHR to track care patterns and zero in on whatever outcome metrics matter most to your leadership.
Because we're not a vendor tied to a single point solution, we provide objective evidence about what's working and what's not. If a solution on our platform isn't improving clinical and operational outcomes, we help diagnose if it's a problem with model accuracy, user adoption, or the workflows connecting model outputs to clinical decisions. Our business model depends on helping you scale AI solutions that deliver value and sunset ones that don't.
Before any solution goes live, we conduct comprehensive retrospective evaluation using your historical patient data (“local validation”). Once integrated, continuous monitoring ensures the system continues performing as expected or flags issues early when intervention is needed. This standardizes monitoring across your entire AI portfolio enables portfolio-level governance in the most cost-effective manner. The alternative is costly and difficult to maintain solution-by-solution monitoring with different metrics and methods.
From Individual Solutions to Portfolio Strategy
When you can monitor comprehensively across all your AI solutions, something powerful becomes possible: strategic portfolio management. You can compare across diverse AI initiatives to identify which solutions deliver the most value in your environment, redirect resources from underperforming tools to high-impact opportunities, and make evidence-based decisions about where to invest next.
This portfolio view also frees capacity for internal innovation. When you're not spending months troubleshooting individual solutions or doing infrastructure maintenance, your team has bandwidth to develop novel solutions optimized for your specific patient populations and operational challenges.
What's Next
We've covered the foundation (infrastructure), the starting point (validated solutions), and the proof (comprehensive monitoring). In our final piece, we'll explore how Vega Health is working with leading health systems to scale their successful AI solutions, turning investments into assets by commercializing innovations to benefit the broader healthcare ecosystem.
Want to learn more about how Vega Health’s monitoring approach can give you objective evidence about your AI investments? Contact us!
